1. Lopez AD, Murray CC. The global burden of disease, 1990–2020. Nat Med 1998; 4(11):1241-3. [DOI via Crossref] [Pubmed] | | 2. Murray CJ, Lopez AD. Evidence-based health policy: lessons from the Global Burden of Disease Study. Science 1996; 6:1593-4. | | 3. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122(11):823–832. | | 4. Sala E, Roca J, Marrades RM, Alonso J, Gonzalez DeSuso JM, Moreno A, Barberá JA, Nadal J, de JoverL, Rodriguez-Roisin R, Wagner PD. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1726–1734. | | 5. Imen Ben Cheikh Rejbi, Yassine Trabelsi, AfefChouchene, Wafa Ben Turkia, Helmi BenSaad, Abdelkarim Zbidi, AbdelhamidKerken, and Zouhair Tabka. Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects. Int J Chron Obstruct Pulmon Dis 2010; 9 (5):209-15. [DOI via Crossref] | | 6. Satta A, Migliori GB, Spanevello A, Neri M, BottinelliR, Canepari M, Pellegrino MA, Reggiani C. Fiber types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10:2853–2860. | | 7. Reid MB : COPD as a muscle disease. Am J Respir Crit Care Med 2001;164 : 1101-5 [DOI via Crossref] [Pubmed] | | 8. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, JobinJ, Carrier G, Maltais F. Midthigh muscle crosssectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002 ; 166 : 809-13. [DOI via Crossref] [Pubmed] | | 9. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G : Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997 ; 10 : 417-23. [DOI via Crossref] | | 10. Steiner MC, Barton RL, Singh SJ, Morgan MD. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003;58(9):745-51. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 11. Laghi F, Adiguzel N, Tobin MJ. Endocrinological derangements in COPD. Eur Respir J 2009; 34(4):975-96. [DOI via Crossref] [Pubmed] | | 12. Van Vliet M, Spruit MA, Verleden G, Kasran A, VanHerck E, Pitta F, Bouillon R, Decramer M.Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172(9):1105-11. [DOI via Crossref] [Pubmed] | | 13. Durand F, Delample D, Poulain M, Préfaut C. Incidence of individualized training on exerciseinduced desaturation in COPD patients. Rev Mal Respir 2007; 24(5):591-8. [DOI via Crossref] | | 14. Mandigout S, Antonini MT, Laforge Q, Lemaire F, Dalmay F, Bouteille B. Contribution à l’étude des effets d’un programme de réentraînement à l’effort sur les aptitudes physiques de patients atteints de bronchopneumopathie chronique obstructive. Science & Sports 2007; 22(6): 300-301. [DOI via Crossref] | | 15. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005 ; 128(4):2025-34. [DOI via Crossref] [Pubmed] | | 16. Drozdowski J, Bakuła S, Drozdowska A, Kedziora K, Porzezioska M, Słomioski JM. The effects of pulmonary rehabilitation on the quality of life in patients with COPD. Pneumonol Alergol Pol. 2007;75(2):147-52. | | 17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1994; 7(6):1197-8. | | 18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117. | | 19. Ben Saad H, Prefaut C, Tabka Z, Mtir AH, ChemitM, Hassaoune R, Ben Abid T, Zara K, Mercier G, ZbidiA, Hayot M. 6-minute walk distance in healthy North Africans older than 40 years: influence of parity. Respir Med 2009;103(1):74–84 | | 20. Vallet G, Ahmaïdi S, Serres I, Fabre C, BourgouinD, Desplan J, Varray A, Préfaut C. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997; 10(1):114-22. [DOI via Crossref] [Pubmed] | | 21. Derom E, Marchand E, Troosters T, Réhabilitation du malade atteint de bronchopneumopathie chronique obstructive . Annales de Réadaptation et de Médecine Physique 2007; 50(7):602-614. [DOI via Crossref] | | 22. Zwick RH, Burghuber OC, Dovjak N, Hartl S, Kossler W, Lichtenschopf A, Muller R, Zwick H. The effect of one year outpatient pulmonary rehabilitation on patients with COPD. Wien Klin Wochenschr. 2009; 121(5-6):189-95. | | 23. Vallet G, Ahmaidi S, Serres I, et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997;10:114–122. | | 24. Casaburi R, Patessio A, Ioli F, Zanaboni S, DonnerCF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143:9–18. | | 25. Scalvini S, Volterrani M, Vitacca M, Clark AL, SolfriniR, Panzali AM, Ferrari R, Levi GF. Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Arch Chest Dis. 1996; 51(5):380-6. | | 26. Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M.Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007; 37(11):897-904. [DOI via Crossref] [Pubmed] | | 27. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGFI stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab. 2004; 287(4):E591-601. | | 28. Lafranco F, Gianotti L, Giordano R, Pellegrino M, Maccario M, Arvat E. Aging, growth hormone and physical performance. J endocrinol Invest 2003; 26(9): 861-72. [DOI via Crossref] | | 29. Koziris LP, Hickson RC, Chatterton RT Jr, GrosethRT, Christie JM, Goldflies DG, Unterman TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 1999; 86(4):1436-42. | | 30. Manetta J, Brun JF, Maimoun L, Callis A, Préfaut C, Mercier J. Effect of training on the GH/IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis. Am J Physiol Endocrinol Metab 2002; 283(5):E929-36. | | 31. Singh MA, Ding W, Manfredi TJ, Solares GS, O'NeillEF, Clements KM, Ryan ND, Kehayias JJ, FieldingRA, Evans WJ. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physio 1999; 277: 135-43. | | 32. Whittom F, Jobin J, Simard PM, Leblanc P, SimardC, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30(10):1467-74. [DOI via Crossref] [Pubmed] | | 33. Craig BW, Brown R, Everhart J. Effects of progressive resistance training on growth hormone and testosterone levels in young and elderly subjects. Mech Ageing Dev 1989; 49(2):159-69. [DOI via Crossref] | | 34. Debigaré R, Marquis K, Côté CH, TremblayRR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124(1):83-9. [DOI via Crossref] [Pubmed] | | 35. Kamischke A, Kemper DE, Castel MA, Luthke M, Rolf C, Behre HM, Magnussen H, Nieschlag E. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J. 1998; 11(1):41-5. [DOI via Crossref] [Pubmed] | | 36. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46:76-80 [DOI via Crossref] | | 37. Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7(3):271-7. Review. | | 38. Semple PD, Beastall GH, Watson WS, Hume R. Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax. 1981; 36(8):605-9. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 39. Gosney JR. Atrophy of Leydig cells in the testes of men with long standing chronic bronchitis and emphysema. Thorax. 1987; 42(8):615-9. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 40. Schoorlemmer RM, Peeters GM, van Schoor NM, Lips P. Relationship between cortisol level, mortality and chronic diseases in older persons. Clin Endocrinol (Oxf). 2009; 71(6):779-86 [DOI via Crossref] [Pubmed] | | 41. Busso T, Häkkinen K, Pakarinen A, Carasso C, LacourJR, Komi PV, Kauhanen H. A systems model of training responses and its relationship to hormonal responses in elite weight-lifters. Eur J Appl Physiol Occup Physiol 1990;61(1-2):48-54. | | 42. Kraemer WJ, Häkkinen K, Newton RU, McCormickM, Nindl BC, Volek JS, Gotshalk LA, FleckSJ, Campbell WW, Gordon SE, Farrell PA, Evans WJ.Acute hormonal responses to heavy resistance exercise in younger and older men. Eur J Appl Physiol Occup Physiol 1998; 77(3):206-11. [DOI via Crossref] [Pubmed] | | 43. Schwab R, Johnson GO, Housh TJ, Kinder JE, Weir JP: Acute effects of different intensities of weight lifting on serum testosterone. Med Sci Sports Exerc 1993; 25(12):1381-5. | | 44. Kraemer WJ, Patton JF, Gordon SE, Harman EA,Deschenes MR, Reynolds K, Newton RU, Triplett NT, Dziados JE. Compatibility of high intensity strength and endurance training on hormonal and skeletal muscle adaptations. J Appl Physiol .1995;78:976-89. | | 45. Alén M, Pakarinen A, Häkkinen K, Komi PV. Responses of serum androgenic-anabolic and catabolic hormones to prolonged strength training. Int J Sports Med 1988; 9(3):229-33. [DOI via Crossref] [Pubmed] | | 46. Häkkinen K, Pakarinen A. Serum hormones and strength development during strength training in middle-aged and elderly males and females. Acta Physiol Scand 1994; 150(2):211-9. [DOI via Crossref] [Pubmed] | | 47. Urban RJ, Bodenburg YH, Gilkison C, FoxworthJ, Coggan AR, Wolfe RR, Ferrando A. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995; 269:820-6. | |
|
|